Sectoral Asset Management »

Crescent Biopharma shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 121k 18.00

More positions owned by Sectoral Asset Management

Contineum Therapeutics Cl A (CTNM)
Shoulder Innovations Common Stock (SI)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Oruka Therapeutics (ORKA)
Biontech Se Sp Adr (BNTX)
Definium Therapeutics Com Shs (DFTX)
Dex (DXCM)
Arcus Biosciences Incorporated (RCUS)
Amgen (AMGN)
Summit Therapeutics (SMMT)
Irhythm Technologies (IRTC)
Abbvie (ABBV)
Merck & Co (MRK)

View all positions for Sectoral Asset Management

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Logos Global Management
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
BlackRock
Tang Capital Management
Vanguard Capital Management
Millennium Management
Geode Capital Management
Jennison Associates

View all funds holding Crescent Biopharma